Kamlesh K. Yadav, MTech, PhD

Assistant Professor
Department of Urology
Icahn School of Medicine at Mount Sinai
One Gustave L. Levy Place
New York, NY 10029, USA

 

Biography

Dr. Yadav has completed PhD at NYU School of Medicine in Cell and Molecular Biology, and a postdoc at Memorial Sloan-Kettering Cancer, NY, looking at prostate cancer drug-resistance. He joined the Department of Urology at Icahn School of Medicine at Mount Sinai, NY in 2014 as Assistant Professor.

Research Interest

His research interests include: Identifying genomic mechanism(s) of drug-resistance development and identification of novel treatment modalities to overcome acquired treatment resistance, primarily in prostate cancer.

Scientific Activities

HONORS AND AWARDS

• Prostate Cancer Foundation 3-year Young Investigator Award, (2014)
• Competitive 2-year Prostate Cancer Research Program (PCRP) post-doctoral fellowship from the US Department of Defense, (2012)
• Competitive Travel Fellowship by the American Society of Biochemistry and Molecular Biology (ASBMS) for the EB 2009 meeting, New Orleans, (2009)
• Graduate School of Arts and Science (GSAS) NYU travel grant (2009)
• Qualified GATE (Graduate Aptitude Test in Engineering) 2001 with 98.10 percentile (Held fellowship at IIT Kanpur during (2001-2002)
• Qualified NET (CSIR-JRF) 2000 (Held fellowship at IIT Kanpur during (2002-2003)
• Banaras Hindu University Gold medal (2001)
• Prof Kanungo Gold medal for outstanding Biochemistry and Mol Bio student (2001)
• Sradha Kumari Srivastava Memorial Award (2001)
• CSIR JRF Fellowship, Govt of India, (2002-2003)
• GATE (98.10 percentile) Fellowship, IIT Kanpur (2001-2002)
• Eastern Coalfields Limited Scholarship (2000-2001 and 1996-1997)
• Education Directorate Scholarship, Government of West Bengal, (1999-2000)
• First Prize for best speaker in Seminar Series (2000-2001)
• First Prize for outstanding participant in Seminar Series (1999-2000)

Publications

1. Yadav KK, Iyengar L, Birkeland NK, Ramanathan G. Transient accumulation of metabolic intermediates of p-Cresol in the culture medium by a Pseudomonas sp strain A isolated from a sewage treatment plant. World Journal of Microbiology and Biotechnology. 2005; 21: 1529-1534.doi: 10.1007/s11274-005-7578-6
2. Tartaglia M, Pennacchio LA, Zhao C, Yadav KK, et al. (Bar-Sagi D, Gelb BD). Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome, Nature Genetics. 2007; 39(1):75-79.
3. Yadav KK, Bar-Sagi D. Allosteric Gating of Sos activity by the Histone Folds domain. PNAS. 2010; 107(8) : 3436-3440.
4. Patgiri A, Yadav KK, Arora PS, Bar-Sagi D. An Orthosteric Inhibitor of the Ras-Sos interaction. Nature Chemical Biology. 2011.doi: 10.1038/nchembio.612.
5. Singh S, Li J, Lavery HJ, Yadav KK, Tewari AK. Next-generation sequencing technology in prostate cancer diagnosis, prognosis, and personalized treatment. Urol Oncol. 2015 doi: 10.1016/j.urolonc.2015.02.009.